Home / Newsletter / The PharmaIndia Weekly | Nov 02 Edition

The PharmaIndia Weekly | Nov 02 Edition


Philips Launches Oxygenate 5 Home Oxygen Concentrator in India

The Story:

Philips has launched Oxygenate 5 in India, a stationary oxygen concentrator designed for long-term home oxygen therapy in patients with chronic respiratory conditions and severe hypoxaemia. Delivering continuous oxygen flow of 0.5–5 L/min, the device features quieter operation, nine-level filtration, user-replaceable filters and extended warranty coverage.

The Take:

The launch expands Philips’ home respiratory care portfolio in India, targeting demand for long-term oxygen therapy beyond hospitals. Pricing, distribution and after-sales service will be key to adoption among patients and healthcare providers.


Zimmer Biomet Launches ROSA Knee with OptimiZe in India

The Story:

Zimmer Biomet has launched ROSA Knee with OptimiZe in India, an advanced robotic-assisted total knee replacement system featuring personalized surgical planning, anatomical landmarking and real-time tracking to support implant positioning and alignment. The system also integrates with the company’s ZBEdge Analytics platform to provide data-driven surgical insights.

The Take:

The launch strengthens Zimmer Biomet’s presence in India’s robotic orthopaedic surgery market, with personalized planning and improved procedural consistency potentially supporting adoption among surgeons and hospitals.


Nucelion Therapeutics Partners with Pandorum on Regenerative Eye Therapies

The Story:

Nucelion Therapeutics, a subsidiary of Bharat Biotech, has partnered with Pandorum Technologies to advance two PRIP-backed ophthalmology programmes targeting advanced keratopathy and wet age-related macular degeneration (AMD). Nucelion will support process development and GMP manufacturing of Pandorum’s designer exosome-based regenerative therapies for clinical studies in India and overseas.

The Take:

The partnership could accelerate the clinical development of exosome-based eye therapies while strengthening India’s domestic regenerative medicine and biomanufacturing capabilities.

Tagged:

Sign Up For Daily Newsletter

Stay updated with our weekly newsletter. Subscribe now to never miss an update!